Immunocore
(IMCR)
undefined
undefined%
At close: undefined
29.86
-0.10%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 249.43M | 143.74M | 26.52M | 30.11M | 25.67M | 23.65M |
| Cost of Revenue | 1.04M | 454.00K | 73.23M | 74.81M | 99.99M | n/a |
| Gross Profit | 248.39M | 143.28M | -46.71M | -44.70M | -74.32M | 23.65M |
| Operating Income | -59.65M | -39.61M | -135.16M | -86.19M | -118.32M | -93.45M |
| Interest Income | 17.99M | 3.15M | 47.00K | 706.00K | 1.40M | 822.00K |
| Pretax Income | -60.89M | -44.15M | -140.93M | -87.36M | -126.19M | -88.18M |
| Net Income | -55.29M | -41.22M | -131.52M | -74.09M | -103.93M | -71.63M |
| Selling & General & Admin | 144.50M | 93.72M | 88.40M | 45.74M | 44.18M | 34.16M |
| Research & Development | 163.54M | 89.17M | 73.23M | 74.81M | 99.99M | 83.58M |
| Other Expenses | n/a | -3.00K | 57.00K | -1.15M | 185.00K | 5.60M |
| Operating Expenses | 308.04M | 182.89M | 161.68M | 119.40M | 144.17M | 117.73M |
| Interest Expense | 5.15M | 7.69M | 5.81M | 3.11M | 3.80M | 842.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 99.99M | 83.58M |
| Cost & Expenses | 309.08M | 183.34M | 161.68M | 119.40M | 144.17M | 117.73M |
| Income Tax | -5.60M | -2.92M | -9.40M | -13.27M | -22.26M | -16.55M |
| Shares Outstanding (Basic) | 48.89M | 45.71M | 42.49M | 31.78M | 27.31M | 27.31M |
| Shares Outstanding (Diluted) | 48.89M | 45.71M | 43.86M | 31.78M | 27.31M | 27.31M |
| EPS (Basic) | -1.13 | -0.9 | -3.1 | -2.33 | -3.81 | -2.62 |
| EPS (Diluted) | -1.13 | -0.9 | -3 | -2.33 | -3.81 | -2.62 |
| EBITDA | -51.65M | -38.35M | -166.72M | -102.59M | -113.18M | -86.75M |
| Depreciation & Amortization | 4.09M | 5.33M | 7.59M | 8.98M | 9.21M | 6.71M |